It is designed as a once-weekly injectable treatment for obesity, working via amylin receptors rather than the GLP-1 pathway used by most current weight loss medications
Helpful resources In case I don't see you, good afternoon, good evening, and good night
Ebrahimi R, Sepand MR, Seyednejad SA, Omidi A, Akbariani M, Gholami M, Sabzevari O (2019) Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the IB/NFB in rats
99% High Purity Product Discreet and Secure Shipping Certified Products For research purposes only
The Croatian Phase I and II trials reported no serious adverse events
Because protein binding has rapid equilibration, the total amount of drug metabolised will be independent of protein binding but highly dependent on liver blood flow